Xagenic rakes in $25.5 mln Series B
Toronto-based molecular diagnostics firm Xagenic said Monday that it has closed $25.5 million in Series B funding. New backer BDC Capital joined the round. In addition to the financing, Dion Madsen, senior managing partner at BDC Capital, has been added to Xagenic's board of director.
14 July 2014•4 mins read
